Literature DB >> 11502632

The use of health-care resources in obesity-hypoventilation syndrome.

G Berg1, K Delaive, J Manfreda, R Walld, M H Kryger.   

Abstract

OBJECTIVE: To document health-care utilization (ie, physician claims and hospitalizations) in patients with obesity-hypoventilation syndrome (OHS), for 5 years prior to the diagnosis and for 2 years after the diagnosis and initiation of treatment.
DESIGN: Retrospective observational cohort study.
SETTING: University-based sleep disorders center in Manitoba, Canada. PATIENTS AND CONTROL
SUBJECTS: Twenty OHS patients (mean [+/- SD] age, 52.7 +/- 9.5 years; body mass index [BMI], 47.3 +/- 11.0 kg/m(2); PaCO(2), 59.7 +/- 13.8 mm Hg; PaO(2), 51.6 +/- 12.4 mm Hg) were matched to two sets of control subjects. First, each case was matched to 15 general population control subjects (GPCs) by age, gender, and geographic location, and, second, each case was matched to a single obese control subject (OBC) who was matched using the same criteria as for the GPCs, plus the measurement of BMI. MEASUREMENTS AND
RESULTS: In the 5 years before diagnosis, the 20 OHS patients had (mean +/- SE) 11.2 +/- 1.8 physician visits per patient per year vs 5.7 +/- 0.8 (p < 0.01) visits for OBCs and 4.5 +/- 0.4 (p < 0.001) visits for GPCs. OHS patients generated higher fees, $623 +/- 96 per patient per year for the 5 years prior to diagnosis compared to $252 +/- 34 (p < 0.001) for OBCs and $236 +/- 25 (p < 0.001) for GPCs. OHS patients were much more likely to be hospitalized than were subjects in either control group in the 5 years prior to diagnosis (odds ratio [OR] vs GPCs, 8.6) (95% confidence interval [CI], 5.9 to 12.7); OR vs OBCs, 4.9 (95% CI, 2.3 to 10.1). In the 2 years after diagnosis and the initiation of treatment (usually continuous positive airway pressure or bilevel positive airway pressure), there was a significant linear reduction in physician fees. In the 2 years after the initiation of treatment, there was a 68.4% decrease in days hospitalized per year (5 years before treatment, 7.9 days per patient per year; after 2 years of treatment, 2.5 days per patient per year [p = 0.01]).
CONCLUSIONS: OHS patients are heavy users of health care for several years prior to evaluation and treatment of their sleep breathing disorder; there is a substantial reduction in days hospitalized once the diagnosis is made and treatment is instituted.

Entities:  

Mesh:

Year:  2001        PMID: 11502632     DOI: 10.1378/chest.120.2.377

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  53 in total

1.  Obesity Hypoventilation Syndrome Epidemiology and Diagnosis.

Authors:  Jay S Balachandran; Juan Fernando Masa; Babak Mokhlesi
Journal:  Sleep Med Clin       Date:  2014-09

2.  Home mechanical ventilation: a Canadian Thoracic Society clinical practice guideline.

Authors:  Douglas A McKim; Jeremy Road; Monica Avendano; Steve Abdool; Fabien Cote; Nigel Duguid; Janet Fraser; Fracois Maltais; Debra L Morrison; Colleen O'Connell; Basil J Petrof; Karen Rimmer; Robert Skomro
Journal:  Can Respir J       Date:  2011 Jul-Aug       Impact factor: 2.409

Review 3.  Respiratory complications of obesity.

Authors:  Swapna Mandal; Nicholas Hart
Journal:  Clin Med (Lond)       Date:  2012-02       Impact factor: 2.659

4.  Modified STOP-BANG questionnaire to predict obesity hypoventilation syndrome in obese subjects with obstructive sleep apnea.

Authors:  Zuleyha Bingol; Aylin Pıhtılı; Esen Kıyan
Journal:  Sleep Breath       Date:  2015-06-06       Impact factor: 2.816

5.  The prevalence of pulmonary hypertension in patients with obesity hypoventilation syndrome: a prospective observational study.

Authors:  Aljohara S Almeneessier; Samar Z Nashwan; Mostafa Q Al-Shamiri; Seithikurippu R Pandi-Perumal; Ahmed S BaHammam
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

6.  Asymptomatic sleep-disordered breathing in premenopausal women awaiting bariatric surgery.

Authors:  Albert Lecube; Gabriel Sampol; Patricia Lloberes; Odile Romero; Jordi Mesa; Ferran Morell; Rafael Simó
Journal:  Obes Surg       Date:  2009-12-18       Impact factor: 4.129

7.  Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea.

Authors:  Pierluigi Carratù; Valentina Anna Ventura; Mauro Maniscalco; Silvano Dragonieri; Simona Berardi; Roberto Ria; Vitaliano Nicola Quaranta; Angelo Vacca; Fiorella Devito; Marco Matteo Ciccone; Barbara Anne Phillips; Onofrio Resta
Journal:  Sleep Breath       Date:  2015-09-18       Impact factor: 2.816

8.  Obesity hypoventilation syndrome.

Authors:  Laila Al Dabal; Ahmed S Bahammam
Journal:  Ann Thorac Med       Date:  2009-04       Impact factor: 2.219

Review 9.  Clinical consequences of altered chemoreflex control.

Authors:  Maria Plataki; Scott A Sands; Atul Malhotra
Journal:  Respir Physiol Neurobiol       Date:  2013-05-13       Impact factor: 1.931

10.  Endothelial dysfunction and specific inflammation in obesity hypoventilation syndrome.

Authors:  Jean-Christian Borel; Pascale Roux-Lombard; Renaud Tamisier; Claire Arnaud; Denis Monneret; Nathalie Arnol; Jean-Philippe Baguet; Patrick Levy; Jean-Louis Pepin
Journal:  PLoS One       Date:  2009-08-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.